Tessera Defense and Homeland Security Inc (HLSQ)
Snapshot
- 1 week
- -4.5%-4.4% vs SPY
- 1 month
- -60.4%-59.6% vs SPY
- Market cap
- $573.3K
- Short % float
- 11.2%
- Days to cover
- 1.0
- Short change
- +134.2%
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Company
Tessera Defense and Homeland Security Inc (HLSQ). Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Dove…
- Michael OsterCEO & Director
- Marina WolfsonSecretaryUSD 350K
- Carl R. MerrilScientific Founder
- Eran ElinavScientific Founder
- Timothy K. LuScientific Founder
- Rotem SorekScientific Founder
Snapshot
Price & returns1 month -60.4%
- 1 week
- -4.5%-4.4% vs SPY
- 1 month
- -60.4%-59.6% vs SPY
Valuationmarket cap $573.3K
- Market cap
- $573.3K
Short interest & optionsshort 11.2% of float
- Short % float
- 11.2%
- Days to cover
- 1.0
- Short change
- +134.2%
Signal evidence
Prediction markets
Kalshi · Polymarket · … linked
Company
Tessera Defense and Homeland Security Inc (HLSQ). Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Dove…
- Michael OsterCEO & Director
- Marina WolfsonSecretaryUSD 350K
- Carl R. MerrilScientific Founder
- Eran ElinavScientific Founder
Earnings history
Loading earnings…
Earnings history
Loading earnings…